Funding for this research was provided by:
Fujian Province Natural Science Foundation (2016J01437)
The Fujian Province Natural Science Foundation (2017J01260)
The Fujian Medical Innovation Project (2015-CX-8)
Joint Funds for the Innovation of Science and Technology, Fujian province (2017Y9074)
Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing (2017 Open Project-9)
the Key Clinical Specialty Discipline Construction Program of Fujian, People’s Republic of China, and the National Clinical Key Specialty Construction Program
Received: 11 September 2018
Accepted: 20 January 2019
First Online: 29 January 2019
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of Fujian Medical University Cancer Hospital, Fuzhou, China (No. KT2016–012-01).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.